TREATMENT WITH HORSE-DERIVED ANTI-THYMOCYTE GLOBULIN LEADS TO ENDURING HEMATOLOGICAL RESPONSES AND A 1.5-YEAR SURVIVAL PROBABILITY OF 87% IN ADULT ACQUIRED APLASTIC ANEMIA PATIENTS IN THE NETHERLANDS
Author(s):
Tjon, J.; Wreede, L. de; Falkenburg, F.; Groot, M. de; Koene, H.; Langemeijer, S.; Meijer, E.; Raaijmakers, M.; Raymakers, R.; Snijders, T.; Zeerleder, S.; Halkes, S.